2. Academic Validation
  3. Polypeptide sono-adjuvant for ultrasound-activatable regulation of innate immunity and cancer vaccination therapy

Polypeptide sono-adjuvant for ultrasound-activatable regulation of innate immunity and cancer vaccination therapy

  • Nat Commun. 2025 Dec 16;17(1):272. doi: 10.1038/s41467-025-66976-2.
Fangmin Chen 1 2,  Huijuan Zhang 1,  Shiqin Li 1,  Siyuan Ren 1 3,  Lujia Huang 1 2,  Yu Guo 1,  Yi Lai 1 2,  Zhixiong Cai 4,  Xiaolong Liu 4,  Zhiai Xu 5,  Haijun Yu 6 7 8 9
Affiliations

Affiliations

  • 1 State Key Laboratory of Chemical Biology & Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
  • 2 University of Chinese Academy of Sciences, Beijing, China.
  • 3 School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, China.
  • 4 The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China.
  • 5 School of Chemistry and Molecular Engineering, East China Normal University, Shanghai, China. [email protected].
  • 6 State Key Laboratory of Chemical Biology & Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China. [email protected].
  • 7 University of Chinese Academy of Sciences, Beijing, China. [email protected].
  • 8 School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, China. [email protected].
  • 9 Yantai Key laboratory of Nanomedicine & Advanced Preparations, Yantai institute of Materia Medica, Yantai, Shandong, China. [email protected].
PMID: 41402324 DOI: 10.1038/s41467-025-66976-2
Abstract

Spatiotemporally-controllable regulation of innate immunity in lymph node remains a critical challenge to implement effective Cancer vaccination. Here we report an ultrasound-activatable strategy to precisely stimulate innate immunity activation in vivo. Mechanistically, ultrasound-triggered mechanical and oxidative forces synchronously activate innate immune pathways in antigen-presenting cells via calcium ion influx and mitochondria DNA release. We next design a polypeptide sono-adjuvant (SONA) library with adjustable physicochemical properties for lymph node-targeting delivery. The top-performed SONA specifically activates robust and durable innate immune responses in lymph node upon localized ultrasound stimulation. The combination of SONA-based vaccine with ultrasound stimulation induces about 3.0-fold higher antigen-specific T cell responses than conventional adjuvant-based vaccines. Moreover, in syngeneic mouse models of orthotopic breast and liver tumors, the combination of SONA-based neoantigen vaccine with ultrasound stimulation markedly boosts immune checkpoint blockade therapy to suppress tumor growth and distant metastasis. Collectively, the polypeptide sono-adjuvant offers great promise for precise regulation of innate immunity and Cancer vaccine therapy.

Figures
Products